Analysis and Commentary STEVEN GROSSMAN 11/22/19 Analysis and Commentary STEVEN GROSSMAN 11/22/19 Time to Talk Turkey ... Once Again Read More Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Continuing Resolution Extends Funding through December 20 Read More STEVEN GROSSMAN 11/21/19 STEVEN GROSSMAN 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More
Analysis and Commentary STEVEN GROSSMAN 11/22/19 Analysis and Commentary STEVEN GROSSMAN 11/22/19 Time to Talk Turkey ... Once Again Read More
Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Continuing Resolution Extends Funding through December 20 Read More
STEVEN GROSSMAN 11/21/19 STEVEN GROSSMAN 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More
Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More
Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More
Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More
Analysis and Commentary STEVEN GROSSMAN 11/1/19 Analysis and Commentary STEVEN GROSSMAN 11/1/19 Another Perspective on the FY 20 Tea Leaves Read More
Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More
